Developing and producing new vaccines for infectious diseases.
Vaccine Manufacturing and Characterization Services
This study is all about creating and testing new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-9724120 on NIH RePORTER |
What this research studies
This research focuses on the manufacturing and characterization of vaccines and biologics aimed at combating infectious diseases, including those that may arise from bioterrorism and drug-resistant pathogens. It involves planning and optimizing vaccine development, ensuring compliance with regulatory standards, and conducting clinical studies. Patients may benefit from the development of new vaccines that could protect against emerging and re-emerging infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk for emerging infectious diseases or those affected by drug-resistant pathogens.
Not a fit: Patients with established vaccines for their conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the introduction of effective vaccines that protect against serious infectious diseases.
How similar studies have performed: Other research has shown success in developing vaccines using similar manufacturing and characterization approaches, indicating a promising path forward.
Where this research is happening
New York, United States
- International AIDS Vaccine Initiative — New York, United States (Active)
Researchers
- Principal investigator: Hassell, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassell, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.